SEARCH

SEARCH BY CITATION

References

  • Almeida, A.M., Khair, K., Hann, I. & Liesner, R. (2003) The use of recombinant factor VIIa in children with inherited platelet function disorders. British Journal of Haematology, 121, 477481.
  • Andrew, M., Castle, V., Mitchell, L. & Paes, B. (1989) Modified bleeding time in the infant. American Journal of Hematology, 30, 190191.
  • Andrew, M., Paes, B., Bowker, J. & Vegh, P. (1990) Evaluation of an automated bleeding time device in the newborn. American Journal of Hematology, 35, 275277.
  • Best, D., Senis, Y.A., Jarvis, G.E., Eagleton, H.J., Roberts, D.J., Saito, T., Jung, S.M., Moroi, M., Harrison, P., Green, F.R. & Watson, S.P. (2003) GPVI levels in platelets: relationship to platelet function at high shear. Blood, 102, 28112818.
  • Bock, M., De Haan, J., Beck, K.H., Gutensohn, K., Hertfelder, H.J., Karger, R., Heim, M.U., Beeser, H., Weber, D. & Kretschmer, V. (1999) Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives. British Journal of Haematology, 106, 898904.
  • Boudewijns, M., Raes, M., Peeters, V., Mewis, A., Cartuyvels, R., Magerman, K. & Rummens, J.L. (2003) Evaluation of platelet function on cord blood in 80 healthy term neonates using the Platelet Function Analyser (PFA-100); shorter in vitro bleeding times in neonates than adults. European Journal of Pediatrics, 162, 212213.
  • British Society for Haematology BCSH Haemostasis and Thrombosis Task Force (1988) Guidelines on platelet function testing. Journal of Clinical Pathology, 41, 13221330.
  • Carcao, M.D., Blanchette, V.S., Dean, J.A., He, L., Kern, M.A., Stain, A.M., Sparling, C.R., Stephens, D., Ryan, G., Freedman, J. & Rand, M.L. (1998) The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. British Journal of Haematology, 101, 7073.
  • Carcao, M.D., Blanchette, V.S., Stephens, D., He, L., Wakefield, C.D., Butchart, S., Christie, D.J. & Rand, M.L. (2002) Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100). British Journal of Haematology, 117, 961964.
  • Cariappa, R., Wilhite, T.R., Parvin, C.A. & Luchtman-Jones, L. (2003) Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. Journal of Pediatric Hematology/oncology, 25, 474479.
  • Cattaneo, M. (2003) Inherited platelet-based bleeding disorders. Journal of Thrombosis and Haemostasis, 1, 16281636.
  • Cattaneo, M. (2004) Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature? Journal of Thrombosis and Haemostasis, 2, 890891.
  • Cattaneo, M., Federici, A.B., Lecchi, A., Agati, B., Lombardi, R., Stabile, F. & Bucciarelli, P. (1999a) Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thrombosis and Haemostasis, 82, 3539.
  • Cattaneo, M., Lecchi, A., Agati, B., Lombardi, R. & Zighetti, M.L. (1999b) Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thrombosis Research, 96, 213217.
  • Dalby, M.C., Davidson, S.J., Burman, J.F. & Davies, S.W. (2000) Diurnal variation in platelet aggregation iwth the PFA-100 platelet function analyser. Platelets, 11, 320324.
  • Dean, J.A., Blanchette, V.S., Carcao, M.D., Stain, A.M., Sparling, C.R., Siekmann, J., Turecek, P.L., Lillicrap, D. & Rand, M.L. (2000) von Willebrand disease in a pediatric-based population–comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thrombosis and Haemostasis, 84, 401409.
  • Di Paola, J., Federici, A.B., Mannucci, P.M., Canciani, M.T., Kritzik, M., Kunicki, T.J. & Nugent, D. (1999) Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood, 93, 35783582.
  • Dyszkiewicz-Korpanty, A., Quinton, R., Yassine, J. & Sarode, R. (2004) The effect of a pneumatic tube transport system on PFA-100 trade mark closure time and whole blood platelet aggregation. Journal of Thrombosis and Haemostasis, 2, 354356.
  • Escolar, G., Pino, M., Reverter, J.C., Diaz-Ricart, M., Pujol, N., Maragall, S., Galan, A.M., Zurbano, M.J. & Ordinas, A. (2001) Precise Differentiation Between Storage Pool Disease and Aspirin Defects using the PFA-100 with a combination of collagen and collagen-arachidonic acid cartridges. Thrombosis and Haemostasis, 86, 395 (abstract).
  • Favaloro, E.J. (2001) Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia, 7, 170179.
  • Favaloro, E.J. (2004) Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients – a rebuttal. Journal of Thrombosis and Haemostasis, 2, 22802282.
  • Favaloro, E.J., Facey, D. & Henniker, A. (1999) Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. American Journal of Hematology, 62, 165174.
  • Favaloro, E.J., Kershaw, G., Bukuya, M., Hertzberg, M. & Koutts, J. (2001) Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies. Haemophilia, 7, 180189.
  • Feusner, J.H. (1980) Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technic. American Journal of Clinical Pathology, 74, 7377.
  • Francis, J.L. (2004) Platelet Function Analyzer (PFA-100). In: Platelets (ed. by A.D.Michelson), pp. 325335. Academic Press, San Diego, CA.
  • Francis, J.L., Francis, D., Larson, L., Helms, E. & Garcia, M. (1999) Can the platelet function analyser (PFA-100) substitute for the bleeding time in routine clinical practice. Platelets, 10, 132136.
  • Fressinaud, E., Veyradier, A., Truchaud, F., Martin, I., Boyer-Neumann, C., Trossaert, M. & Meyer, D. (1998) Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood, 91, 13251331.
  • Fressinaud, E., Veyradier, A., Sigaud, M., Boyer-Neumann, C., Le Boterff, C. & Meyer, D. (1999) Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates. British Journal of Haematology, 106, 777783.
  • Hajdenberg, J. (2004) Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients – a rebuttal. Journal of Thrombosis and Haemostasis, 2, 22822283.
  • Harrison, P. (2000) Progress in the assessment of platelet function. British Journal of Haematology, 111, 733744.
  • Harrison, P. (2004) In vitro measurement of high-shear platelet adhesion and aggregation by the PFA-100. Methods in Molecular Biology, 272, 215223.
  • Harrison, P. (2005) Platelet function analysis. Blood Reviews, 19, 111123.
  • Harrison, P., Robinson, M.S., Mackie, I.J., Joseph, J., McDonald, S.J., Liesner, R., Savidge, G.F., Pasi, J. & Machin, S.J. (1999) Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis. Blood Coagulation and Fibrinolysis, 10, 2531.
  • Harrison, C., Khair, K., Baxter, B., Russell-Eggitt, I., Hann, I. & Liesner, R. (2002b ) Hermansky-Pudlak syndrome: infrequent bleeding and first report of Turkish and Pakistani kindreds. Archives of Disease in Childhood, 86, 297301.
  • Harrison, P., Robinson, M., Liesner, R., Khair, K., Cohen, H., Mackie, I. & Machin, S. (2002a ) The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clinical and Laboratory Haematology, 24, 225232.
  • Harrison, P., Segal, H., Furtado, C., Verjee, S., Sukhu, K. & Murphy, M.F. (2004) High incidence of defective high-shear platelet function among platelet donors. Transfusion, 44, 764770.
  • Homoncik, M., Jilma, B., Hergovich, N., Stohlawetz, P., Panzer, S. & Speiser, W. (2000) Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thrombosis and Haemostasis, 83, 316321.
  • Israels, S.J., Cheang, T., McMillan-Ward, E.M. & Cheang, M. (2001) Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. Journal of Pediatrics, 138, 116119.
  • Jilma, B. (2001) Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. Journal of Laboratory and Clinical Medicine, 138, 152163.
  • Jilma-Stohlawetz, P., Hergovich, N., Homoncik, M., Dzirlo, L., Horvath, M., Janisiw, M., Panzer, S. & Jilma, B. (2001) Impaired platelet function among platelet donors. Thrombosis and Haemostasis, 86, 880886.
  • Kerenyi, A., Schlammadinger, A., Ajzner, E., Szegedi, I., Kiss, C., Pap, Z., Boda, Z. & Muszbek, L. (1999) Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function. Thrombosis Research, 96, 487492.
  • Koscielny, J., Ziemer, S., Radtke, H., Schmutzler, M., Pruss, A., Sinha, P., Salama, A., Kiesewetter, H. & Latza, R. (2004a) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clinical Applications of Thrombosis and Hemostasis, 10, 195204.
  • Koscielny, J., von Tempelhoff, G.F., Ziemer, S., Radtke, H., Schmutzler, M., Sinha, P., Salama, A., Kiesewetter, H. & Latza, R. (2004b) A practical concept for preoperative management of patients with impaired primary hemostasis. Clinical Applications of Thrombosis and Hemostasis, 10, 155166.
  • Kottke-Marchant, K., Powers, J.B., Brooks, L., Kundu, S. & Christie, D.J. (1999) The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100). Clinical Applications of Thrombosis and Hemostasis, 5, 122130.
  • Kratzer, M.A. & Born, G.V. (1985) Simulation of primary haemostasis in vitro. Haemostasis, 15, 357362.
  • Kundu, S.K., Heilmann, E.J., Sio, R., Garcia, C., Davidson, R.M. & Ostgaard, R.A. (1995) Description of an in vitro platelet function analyzer – PFA-100. Seminars in Thrombosis and Hemostasis, 21 (Suppl. 2), 106112.
  • Kundu, S.K., Heilmann, E.J., Sio, R., Garcia, C. & Ostgaard, R.A. (1996) Characterization of an in vitro platelet function analyzer – PFA-100. Clinical Applications of Thrombosis and Hemostasis, 2, 241249.
  • Liesner, R., Hann, I. & Khair, K. (2004) Non-accidental injury and the haematologist: the causes and investigation of easy bruising. Blood Coagulation and Fibrinolysis, 15 (Suppl. 1), S41S48.
  • Lind, S.E. (2002) The bleeding time. In: Platelets (ed. by A.D.Michelson), pp. 283289. Academic Press, San Diego, CA.
  • Mammen, E.F., Comp, P.C., Gosselin, R., Greenberg, C., Hoots, W.K., Kessler, C.M., Larkin, E.C., Liles, D. & Nugent, D.J. (1998) PFA-100 system: a new method for assessment of platelet dysfunction. Seminars in Thrombosis and Hemostasis, 24, 195202.
  • Moeller, A., Weippert-Kretschmer, M., Prinz, H. & Kretschmer, V. (2001) Influence of ABO blood groups on primary hemostasis. Transfusion, 41, 5660.
  • Pearson, D.A., Paglieroni, T.G., Rein, D., Wun, T., Schramm, D.D., Wang, J.F., Holt, R.R., Gosselin, R., Schmitz, H.H. & Keen, C.L. (2002) The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thrombosis Research, 106, 191197.
  • Podda, G., Bucciarelli, P., Lussana, F. & Cattaneo, M. (2005) Are the PFA-100 Closure Time and the Skin Bleeding Time useful in the Diagnostic work-up of Patients with Bleeding Diathesis? Correlation with the Severity of Bleeding Symptoms and sensitivity for known defects of primary haemostasis. Blood, 104, 3037 (abstract).
  • Quiroga, T., Goycoolea, M., Munoz, B., Morales, M., Aranda, E., Panes, O., Pereira, J. & Mezzano, D. (2004a) Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. Journal of Thrombosis and Hemostasis, 2, 892898.
  • Quiroga, T., Pereira, J. & Mezzano, D. (2004b) Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients – a reply to rebuttals. Journal of Thrombosis and Hemostasis, 2, 22832285.
  • Rand, M.L., Carcao, M.D. & Blanchette, V.S. (1998) Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting. Seminars in Thrombosis and Hemostasis, 24, 523529.
  • Rand, M.L., Leung, R. & Packham, M.A. (2003) Platelet function assays. Transfus Apheresis Science, 28, 307317.
  • Rodgers, R.P. & Levin, J. (1990) A critical reappraisal of the bleeding time. Seminars in Thrombosis and Hemostasis, 16, 120.
  • Salama, M.E., Raman, S., Drew, M.J., Abdel-Raheem, M. & Mahmood, M.N. (2004) Platelet function testing to assess effectiveness of platelet transfusion therapy. Transfus Apheresis Sciences, 30, 93100.
  • Sanders, J.M., Holtkamp, C.A. & Buchanan, G.R. (1990) The bleeding time may be longer in children than in adults. American Journal of Pediatric Hematology andOncology, 12, 314318.